PFKFB3 and atherosclerosis: Notably, this network integrates key glycolytic regulators like PFKFB3 and lactate transporters like MCT1 with established inflammatory and signaling pathways, providing a computational framework and promising targets for future mechanistic and therapeutic research in atherosclerosis [45].